This brings the total funding in FY25 (April-February) to $25.4 billion, spread across 2,200 rounds, according to data from Traxcn. The Feb...

Perfios acquired fraud detection platform Clari5 to enhance its fraud management capabilities. Clari5, with 200 employees, becomes a Perfio...

Happy Thursday! Swiggy delivered big on its market debut on Wednesday, leading to substantial gains for both early investors and employees....

"The Boards of Directors of both companies have approved the proposed acquisition, which is expected to close in the second half of 2017," ...

The business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...

They are scouting for niche manufacturing sites, promising experimental drugs, specialty firms in emerging markets and opportunities in the...

The only way you can increase your US sales is by that acquisition in generics and keep on investing in R&D to get a product which will boo...

Hyderabad-headquartered Gland is a leading contract manufacturers of injectables, supplying to pharma majors in India and US like Dr Reddy’...

The S&P BSE Sensex surged over 500 points on Monday following positive trend across globe, especially the Asian and European markets.

Both sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...

The benchmark Nifty index slipped below its 200-day moving average for the first time in nearly 15 months on Monday.

Mitsui is stepping up its focus on India, with a special eye on infrastructure development, energy and lifestyle as it seeks newer growth a...

Ending months of soul searching, Suzlon promoter Tulsi Tanti decided to lighten up Suzlon's stretched balance sheet by selling his German c...

Nearly 52K people are employed in Gujarat’s pharmaceutical sector, which has witnessed 54% CAGR in capital investments over the last three ...

Private equity investments in India doubled to $8 billion in 2010, from a year earlier. But there were hardly any buyouts.

I-bankers, acting on behalf of Strides, have signalled M&A interest on part of the promoter group for its speciality pharma and R&D units.

Global private equity firm Carlyle has raised $668m for its latest Asia specific growth capital fund. The fund, called the Carlyle Asia Gro...